Angelini Pharma S.p.A., Rom, Zweigniederlassung Zug - Ontozry 150 mg, Filmtabletten | | 68051 | | 05 | | Ontozry 150 mg | | Filmtabletten | | N03AX25 | | Cenobamate | | 19.05.2022 | | |
| Composition | cenobamatum 150 mg, cellulosum microcristallinum, lactosum monohydricum 163.02 mg, carboxymethylamylum natricum A corresp. natrium 0.96 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 4000, talcum, E 172 (flavum), E 172 (rubrum), pro compresso obducto. | Packungsbestandteile | | Comprimés filmés | | | Principe actif | Concentr. |
---|
Cenobamatum | 150 mg |
| BAG: Principe actif | Concentr. |
---|
Cenobamatum | 150 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Flavum) | | | (Rubrum) | | | Carboxymethylamylum Natricum A | | | Cellulosum Microcristallinum | | | E 171 | | color. | E 172 | | color. | Lactose Monohydrate | 163.02 mg | | Macrogol | 4000 | | Magnesii Stearas | | | Poly(Alcohol Vinylicus) | | Überzug | Pro Compresso Obducto | | | Silica Colloidalis Anhydrica | | | Talcum | | |
| |
| |
|